Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 467

1.

Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.

Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ.

J Infect Dis. 2005 Dec 1;192(11):1943-9. Epub 2005 Nov 2.

PMID:
16267765
2.

Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.

Neau D, Winnock M, Castéra L, Bail BL, Loko MA, Géraut L, Dupon M, Ragnaud JM, Lacoste D, Lafon ME, Bioulac-Sage P, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):168-73.

PMID:
17527092
3.

Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.

Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D; Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA).

Aliment Pharmacol Ther. 2007 Dec;26(11-12):1489-98. Epub 2007 Sep 28.

4.

HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.

Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.

Antivir Ther. 2008;13(8):1057-65.

PMID:
19195331
5.

Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.

Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S; ANRS HC02 - Ribavic Study team.

AIDS. 2006 Feb 28;20(4):525-31.

PMID:
16470116
6.

Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.

Monto A, Dove LM, Bostrom A, Kakar S, Tien PC, Wright TL.

Hepatology. 2005 Aug;42(2):310-6.

PMID:
16025515
7.

Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.

Bani-Sadr F, Barange K, Daoud F, Jacomet C, Bicart-See A, Rosenthal E, Cacoub P, Pol S, Perronne C, Carrat F; ANRS HC02 - Ribavic Study Team.

HIV Med. 2009 Aug;10(7):417-21. doi: 10.1111/j.1468-1293.2009.00702.x. Epub 2009 Mar 26.

8.
9.
10.

Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.

García-Samaniego J, Soriano V, Castilla J, Bravo R, Moreno A, Carbó J, Iñiguez A, González J, Muñoz F.

Am J Gastroenterol. 1997 Jul;92(7):1130-4.

PMID:
9219784
11.

Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis.

Thomopoulos KC, Arvaniti V, Tsamantas AC, Dimitropoulou D, Gogos CA, Siagris D, Theocharis GJ, Labropoulou-Karatza C.

Eur J Gastroenterol Hepatol. 2006 Mar;18(3):233-7.

PMID:
16462535
12.

Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.

Matos CA, Perez RM, Pacheco MS, Figueiredo-Mendes CG, Lopes-Neto E, Oliveira EB Jr, Lanzoni VP, Silva AE, Ferraz ML.

J Gastroenterol Hepatol. 2006 Aug;21(8):1236-9.

PMID:
16872303
13.

Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.

Peng D, Han Y, Ding H, Wei L.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1082-8. doi: 10.1111/j.1440-1746.2008.05478.x.

PMID:
18707599
14.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
15.

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection.

Shi JP, Fan JG, Wu R, Gao XQ, Zhang L, Wang H, Farrell GC.

J Gastroenterol Hepatol. 2008 Sep;23(9):1419-25. doi: 10.1111/j.1440-1746.2008.05531.x.

PMID:
18853998
16.

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL.

AIDS. 2005 Mar 24;19(6):585-92.

PMID:
15802977
17.

Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.

Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.

Aliment Pharmacol Ther. 2009 Jul;30(1):61-70. doi: 10.1111/j.1365-2036.2009.03995.x. Epub 2009 Mar 9.

18.

Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.

Rodríguez-Torres M, Govindarajan S, Solá R, Clumeck N, Lissen E, Pessôa M, Buggisch P, Main J, Depamphilis J, Dieterich DT.

J Hepatol. 2008 May;48(5):756-64. doi: 10.1016/j.jhep.2008.01.015. Epub 2008 Feb 7.

PMID:
18314217
19.

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.

Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, Gouérou H.

Gastroenterol Clin Biol. 2004 Mar;28(3):272-8.

20.

[Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].

Coral G, de Mattos AA, de Mattos AZ, dos Santos DE.

Arq Gastroenterol. 2006 Oct-Dec;43(4):265-8. Portuguese.

Supplemental Content

Support Center